Filing Details

Accession Number:
0001209191-11-002346
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-01-06 19:05:33
Reporting Period:
2011-01-04
Filing Date:
2011-01-06
Accepted Time:
2011-01-06 19:05:33
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
949858 Oncogenex Pharmaceuticals Inc. OGXI In Vitro & In Vivo Diagnostic Substances (2835) 954343413
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1442675 Daniel Scott Cormack 400-1001 W. Broadway
Vancouver A1 V6H 4B1
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-01-04 6,608 $3.89 19,675 No 4 M Direct
Common Stock Disposition 2011-01-04 6,608 $16.52 13,067 No 4 S Direct
Common Stock Acquisiton 2011-01-04 3,392 $3.89 11,484 No 4 M Indirect Spouse
Common Stock Disposition 2011-01-04 3,392 $16.52 8,092 No 4 S Indirect Spouse
Common Stock Acquisiton 2011-01-05 8,660 $3.89 21,727 No 4 M Direct
Common Stock Disposition 2011-01-05 8,660 $0.00 13,067 No 4 G Direct
Common Stock Acquisiton 2011-01-05 8,660 $0.00 44,340 No 4 G Indirect By Trycor Investment Trust No. 1
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Indirect Spouse
No 4 S Indirect Spouse
No 4 M Direct
No 4 G Direct
No 4 G Indirect By Trycor Investment Trust No. 1
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Options Disposition 2011-01-04 6,608 $0.00 6,608 $3.89
Common Stock Options Disposition 2011-01-04 3,392 $0.00 3,392 $3.89
Common Stock Options Disposition 2011-01-05 8,660 $0.00 8,660 $3.89
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
8,660 2007-01-14 2011-01-14 No 4 M Direct
0 2007-01-14 2011-01-14 No 4 M Indirect
0 2007-01-14 2011-01-14 No 4 M Direct
Footnotes
  1. Scott Cormack and his spouse are the trustees and beneficiaries of the Trycor Investment Trust No. 1
  2. These shares were exercised and sold under the 10b5 Sales Plan.
  3. These shares were exercised under the 10b5 Sales Plan.